Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 1954-1958, April 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mivechi, N. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mivechi, N. F.

Heat Sensitivity, Thermotolerance, and Profile of Heat Shock Protein Synthesis of Human Myelogenous Leukemias1

Nahid F. Mivechi2

Department of Radiation Research, City of Hope National Medical Center, Duarte, California 91010

In anticipation of using single or fractionated hyperthermia treatment in ex vivo purging of leukemic bone marrow in the clinic, we have compared the hyperthermic sensitivity, kinetics of thermotolerance, and heat-shock protein synthesis in three human myelogenous leukemic cell lines. In terms of heat sensitivity, the chronic myelogenous leukemic cell line K562 was found to be the most resistant. The Dos of the 43, 44, and 45°C heat survival curves were 22, 13, and 6 min, respectively. HL-60 and KG-1, both acute myelogenous leukemic lines, however, were found to be several fold more sensitive to the cytotoxic effects of heat. The Dos of the 43, 44, and 45°C heat survival curves for HL-60 were 7.6, 5.6, and 2 min and for KG-1 were 5.7, 4.5, and 1.7 min, respectively.

All cell lines developed thermotolerance. However, K562 developed more tolerance which lasted for longer times. For K562 cells at priming heat doses of 45°C/10 min, 42°C/2 h, or 41°C/2 h thermotolerance was maximum at 4 to 6 h and began to decay at 24 h. HL-60 and KG-1 cells showed some thermotolerance at the priming doses of 45°C/5 min or 42°C/30 min and had fully decayed by 24 h. K562 cells synthesized Mr 70,000 heat shock protein for over 24 h following the 45°C/10 min heat shock, while HL-60 and KG-1 synthesized Mr 70,000 heat shock protein for 2–4 h for the same amount of cell kill. These studies suggest that most human leukemias may be extremely sensitive to the cytotoxic effects of heat, and in vitro purging of leukemias from bone marrow specimens by heat needs to be further studied both by in vitro and in vivo model systems.

1 This work was supported by NIH Grant CA 33572.

2 To whom requests for reprints should be addressed, at Department of Radiation Research, City of Hope National Medical Center, 1500 E. Duarte Road, Duarte, CA 91010-0269.

Received 8/ 1/88. Revised 11/15/88. Accepted 1/17/89.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
N. Vilaboa, C Calle, C Perez, E de Blas, L Garcia-Bermejo, and P Aller
cAMP increasing agents prevent the stimulation of heat-shock protein 70 (HSP70) gene expression by cadmium chloride in human myeloid cell lines
J. Cell Sci., January 8, 1995; 108(8): 2877 - 2883.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
S. Leppa, R. Kajanne, L. Arminen, and L. Sistonen
Differential Induction of Hsp70-encoding Genes in Human Hematopoietic Cells
J. Biol. Chem., August 17, 2001; 276(34): 31713 - 31719.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.